July 7, 2020 Research Bulletin

Special Announcements

Vascular Surgery COVID-19 Collaborative (VASCC)

In response to the COVID-19 pandemic, the Vascular Surgery COVID-19 Collaborative (VASCC) was founded by Max Wohlauer, M.D. in March to assess the impact of COVID-19 on the care of patients with vascular disease. Currently, VASCC is beginning two studies to evaluate the effect of postponement of vascular surgery on patient outcomes around the world due the COVID-19.   

Learn more about the VASCC study and upcoming projects

Feature Funding Opportunities

The American Foundation for Suicide Prevention (AFSP)

The foundation supports studies that will increase understanding of suicide or test treatments and other interventions to save lives.     

Innovation Grants

LOI due: September
15 Application due: November 15     

Focus Grants

LOI due: August 1
Invited full applications are due December 7; provides up to $500,000 over 3 years

Additional July 2020 feature funding opportunities

Collaborative Research Opportunities

Stand Up To Cancer (SU2C)

About SU2C: Stand Up To Cancer breaks down the traditional barriers to collaboration by allowing scientists ad researchers across institutions and disciplines to come together and work toward a shared goal: beating cancer. 

What's New at Stand Up To Cancer Program: Health Equity Breakthrough Team Research Grant Program 

LOI Due: September 1

Interested in collaborative research?  Do you have a collaborative research funding opportunity you would like to announce or are you searching for a collaborator on a specific proposal?     

Collaborations between research groups are growing, and the collaborating groups can be across the hall, University of Colorado campuses, the country, or the globe. Scholars or groups in different fields work together on interdisciplinary projects.   

The OVCR wants to offer this space on a bi-weekly basis for promotion of collaborative research funding opportunities (internal and external funding) and solicitations for prospective interdisciplinary collaborators for proposed funding applications.     

Send inquires to ResearchAdminComm@CUAnschutz.edu

NIH Funding Announcements

Just Released

The High-Risk High-Reward Research Program and other Common Fund programs are managed by the Office of Strategic Coordination, Division of Program Coordination, Planning, and Strategic Initiatives in the NIH Office of the Director, in partnership with the component NIH Institutes, Centers, and Offices. The NIH Common Fund encourages collaboration and supports a series of exceptionally high impact, trans-NIH programs. The National Institutes of Health (NIH) –“The Nation's Medical Research Agency” – includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. 

For more information about NIH and its programs, visit the NIH website.     

FY2021 NIH Director’s Transformative Research Award (R01 - Clinical Trial Optional): 

RFA RM-20-013

Supports individuals or teams proposing that are inherently risky and untested but have the potential to create or overturn fundamental paradigms. An anonymized review process will be used. 

• Open to all career stages
• Application deadline: September 30   

FY2021 NIH Director’s Emergency Transformative Research Award (R01 - Clinical Trial Optional): COVID-19 Proposals

RFA RM-20-020

Supports individuals or teams proposing COVID-19-related projects that are inherently risky and untested but have the potential to create or overturn fundamental paradigms. An anonymized review process will be used. 

• Open to all career stages
• Application deadline: September 30

This bulletin is distributed on the 1st & 3rd Tuesday of the month for the CU Anschutz Research Community.     

Please click here if you wish to be added to this distribution.